1. Influence of dysregulated expression of circular RNA on the diagnosis and prognosis of breast cancer in Asia: a meta-analysis study
- Author
-
Huixia Zhu, Feng Wang, Fengyuan Liu, and Xinrui Wu
- Subjects
Oncology ,medicine.medical_specialty ,Asia ,Breast surgery ,medicine.medical_treatment ,Breast Neoplasms ,Cochrane Library ,Breast cancer ,Circular RNA ,general medicine (see internal medicine) ,Internal medicine ,Overall survival ,Biomarkers, Tumor ,Medicine ,molecular biology ,Humans ,business.industry ,Area under the curve ,General Medicine ,RNA, Circular ,breast surgery ,medicine.disease ,Prognosis ,Meta-analysis ,Biomarker (medicine) ,Female ,business - Abstract
ObjectiveRecent studies have reported a correlation between non-coding RNAs such as circular RNAs (circRNAs) and clinical value of various cancers. However, the diagnostic and prognostic role of circRNA in breast cancer remains controversial.DesignSystematic review and meta-analysis.MethodsDiagnostic efficacy was estimated by sensitivity, specificity and area under the curve (AUC). Pooled HRs with 95% CIs estimated overall survival (OS), and ORs with 95% CIs investigated clinical features.ResultsBy searching PubMed, Embase, Web of Science, CNKI and Cochrane Library, we obtained a total of 29 studies with 4405 patients. A shorter survival time was associated with high expression levels of tumour-promoter circRNAs (OS: HR=2.43, 95% CI 2.20 to 2.92, pConclusionDysregulated expression of circRNA was related to diagnosis and prognosis in breast cancer, which indicated it might be a novel biomarker and a target of therapy for breast cancer.PROSPERO registration numberCRD42020207912.
- Published
- 2021